{"id":828009,"date":"2025-03-20T08:36:42","date_gmt":"2025-03-20T12:36:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\/"},"modified":"2025-03-20T08:36:42","modified_gmt":"2025-03-20T12:36:42","slug":"autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\/","title":{"rendered":"Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company\u2019s Proprietary Catheter-Based Technology"},"content":{"rendered":"
\n

\n Continued progress with growing global patent portfolio to over 80 issued patents and 40 pending patent applications\u00a0<\/em>\n <\/p>\n

\n Proprietary sensing and ablation technology has demonstrated potential to more precisely target and eliminate overactive nerves, improving response rates and enhancing patient outcomes across multiple indications<\/em>\n <\/p>\n

\n THE WOODLANDS, TX, March 20, 2025 (GLOBE NEWSWIRE) — <\/strong>
\n
\n Autonomix Medical, Inc.<\/u>
\n <\/a> (NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. patent 12,217,863 (\u2018863 patent) titled, Medical Devices with Circuitry for Capturing and Processing Physiological Signals<\/em>. The issued \u2018863 patent gives Autonomix protection of proprietary technology used to collect and process sensing data for real-time physiological monitoring with broad application use that includes, e.g., heart mapping, arterial mapping, parenchymal monitoring, central nervous system monitoring and implant, robotic and wearable precision applications.<\/p>\n

\u201cWe are pleased to strengthen our patent protection for this potential groundbreaking technology. The continued positive data on its application, efficacy, and safety reinforce our confidence in its potential.\u00a0<\/strong>We remain committed to advancing this innovation to address critical areas of unmet medical need. To date, our early clinical results have been highly encouraging for reducing pancreatic cancer pain. Beyond cancer pain, our technology holds promise for a broad range of conditions where nerve activity plays a key role, including hypertension within the cardiovascular space,\u201d commented Brad Hauser, CEO of Autonomix.<\/p>\n

Autonomix\u2019s first-in-class technology platform utilizes a catheter-based microchip sensing array antenna that may have the ability to detect and differentiate neural signals with up to 3,000 times greater sensitivity than currently available technologies. Once target nerves are identified, Autonomix uses its proprietary RF ablation technology to kill targeted nerves, enabling a precision guided sense, treat and verify approach to addressing a number of disease categories from chronic pain management to hypertension and cardiology. Current approaches, primarily relying on opioids or invasive ethanol injections, can provide only limited relief and may lead to risky side effects.<\/p>\n

The Company expects to submit an IDE and commence U.S. clinical trials in 2025 to support a labeling indication to commercialize the Autonomix Sensing and RF Ablation System in the U.S. as a treatment for pancreatic cancer pain.<\/p>\n

For more information about the Company\u2019s technology, please visit\u00a0autonomix.com<\/u><\/a>.<\/p>\n

\n About Autonomix Medical, Inc.<\/strong>\n <\/p>\n

Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company\u2019s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with up to 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.<\/p>\n

We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States.<\/p>\n

For more information, visit\u00a0autonomix.com<\/u><\/a> and connect with the Company on X<\/u><\/a>, LinkedIn<\/u><\/a>, Instagram<\/u><\/a> and Facebook<\/u><\/a>.<\/p>\n

\n Forward Looking Statements<\/strong>\n <\/p>\n

Some of the statements in this release are \u201cforward-looking statements,\u201d which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the potential of the technology to treat cancerous tumors and the pain associated with pancreatic cancer, to submit and receive approval of an IDE, and to file a De Novo application. Such forward-looking statements can be identified by the use of words such as \u201cshould,\u201d \u201cmight,\u201d \u201cmay,\u201d \u201cintends,\u201d \u201canticipates,\u201d \u201cbelieves,\u201d \u201cestimates,\u201d \u201cprojects,\u201d \u201cforecasts,\u201d \u201cexpects,\u201d \u201cplans,\u201d and \u201cproposes.\u201d<\/p>\n

Although Autonomix believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading \u201cRisk Factors\u201d and elsewhere in the Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (SEC) on May 31, 2024, and from time to time, our other filings with the SEC. Forward-looking statements speak only as of the date of the document in which they are contained and Autonomix does not undertake any duty to update any forward-looking statements except as may be required by law.<\/p>\n

\n Investor and Media Contact<\/strong>\n <\/p>\n

JTC Team, LLC
Jenene Thomas
908.824.0775
autonomix@jtcir.com<\/u><\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Continued progress with growing global patent portfolio to over 80 issued patents and 40 pending patent applications\u00a0 Proprietary sensing and ablation technology has demonstrated potential to more precisely target and eliminate overactive nerves, improving response rates and enhancing patient outcomes across multiple indications THE WOODLANDS, TX, March 20, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. patent 12,217,863 (\u2018863 patent) titled, Medical Devices with Circuitry for Capturing and Processing Physiological Signals. The issued \u2018863 patent gives Autonomix protection of proprietary … <\/p>\n

Continue reading “Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company\u2019s Proprietary Catheter-Based Technology”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-828009","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAutonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company\u2019s Proprietary Catheter-Based Technology - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company\u2019s Proprietary Catheter-Based Technology - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Continued progress with growing global patent portfolio to over 80 issued patents and 40 pending patent applications\u00a0 Proprietary sensing and ablation technology has demonstrated potential to more precisely target and eliminate overactive nerves, improving response rates and enhancing patient outcomes across multiple indications THE WOODLANDS, TX, March 20, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. patent 12,217,863 (\u2018863 patent) titled, Medical Devices with Circuitry for Capturing and Processing Physiological Signals. The issued \u2018863 patent gives Autonomix protection of proprietary … Continue reading "Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company\u2019s Proprietary Catheter-Based Technology"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-20T12:36:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5Nzg2OCM2ODE1ODA3IzUwMDExOTk5Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company\u2019s Proprietary Catheter-Based Technology\",\"datePublished\":\"2025-03-20T12:36:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\\\/\"},\"wordCount\":801,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5Nzg2OCM2ODE1ODA3IzUwMDExOTk5Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\\\/\",\"name\":\"Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company\u2019s Proprietary Catheter-Based Technology - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5Nzg2OCM2ODE1ODA3IzUwMDExOTk5Mg==\",\"datePublished\":\"2025-03-20T12:36:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5Nzg2OCM2ODE1ODA3IzUwMDExOTk5Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5Nzg2OCM2ODE1ODA3IzUwMDExOTk5Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company\u2019s Proprietary Catheter-Based Technology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company\u2019s Proprietary Catheter-Based Technology - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\/","og_locale":"en_US","og_type":"article","og_title":"Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company\u2019s Proprietary Catheter-Based Technology - Market Newsdesk","og_description":"Continued progress with growing global patent portfolio to over 80 issued patents and 40 pending patent applications\u00a0 Proprietary sensing and ablation technology has demonstrated potential to more precisely target and eliminate overactive nerves, improving response rates and enhancing patient outcomes across multiple indications THE WOODLANDS, TX, March 20, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. patent 12,217,863 (\u2018863 patent) titled, Medical Devices with Circuitry for Capturing and Processing Physiological Signals. The issued \u2018863 patent gives Autonomix protection of proprietary … Continue reading \"Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company\u2019s Proprietary Catheter-Based Technology\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-20T12:36:42+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5Nzg2OCM2ODE1ODA3IzUwMDExOTk5Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company\u2019s Proprietary Catheter-Based Technology","datePublished":"2025-03-20T12:36:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\/"},"wordCount":801,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5Nzg2OCM2ODE1ODA3IzUwMDExOTk5Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\/","name":"Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company\u2019s Proprietary Catheter-Based Technology - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5Nzg2OCM2ODE1ODA3IzUwMDExOTk5Mg==","datePublished":"2025-03-20T12:36:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5Nzg2OCM2ODE1ODA3IzUwMDExOTk5Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5Nzg2OCM2ODE1ODA3IzUwMDExOTk5Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-granted-u-s-patent-covering-sensing-data-collection-and-processing-with-companys-proprietary-catheter-based-technology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company\u2019s Proprietary Catheter-Based Technology"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/828009","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=828009"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/828009\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=828009"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=828009"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=828009"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}